<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396901</url>
  </required_header>
  <id_info>
    <org_study_id>SDC 4163/14/143</org_study_id>
    <nct_id>NCT02396901</nct_id>
  </id_info>
  <brief_title>Goal Direct Therapy to Prevent Acute Kidney Injury</brief_title>
  <acronym>GDT-AKI</acronym>
  <official_title>Goal Direct Therapy to Prevent Acute Kidney Injury After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an randomised controlled trial to investigate an strategy based in a protocol in
      prevention of acute kidney injury after cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized controlled trial to assess the influence of use of
      angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in
      the development of the Acute Kidney Injury in the postoperative period of cardiac surgery.
      Patients undergoing cardiac surgery at the Heart Institute (InCor) - Brazil, will be
      randomized and in accordance with a list of random numbers, generated by a computer program,
      will be allocated in one of the groups (GDT or standard).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>Within 48h after cardiac surgery</time_frame>
    <description>Development of acute kidney injury according to AKIN (Acute Kidney Injury Network) criterion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serious clinical complications</measure>
    <time_frame>For 28 days</time_frame>
    <description>Defined according to the guidelines of the Society of Thoracic Surgeons and include: stroke, need for invasive mechanical ventilation for more than 48 hours, mediastinitis, or deep infection of the surgical wound, mortality, need for reoperation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">214</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>GDT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the GDT Group will care from a protective strategy with the suspension of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) 48 hours before surgery and receive hydration with lactated Ringer's solution at the rate of 1 mL/kg/h in the night before the surgery until the surgical procedure and perioperative hemodynamic therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients randomized to the control group will be treated in accordance with the care in the institution's routine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Goal Direct Therapy</intervention_name>
    <description>Goal Direct Therapy - in this group patients will receive the standard treatment according with institutional protocol.</description>
    <arm_group_label>GDT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgery with Cardiopulmonary Bypass (CPB); Age greater than 18 years; Chronic
             kidney disease stages 3 and 4 (GFR less than 60 mL/min and greater than 15 mL/min);
             Sign the informed consent form.

        Exclusion Criteria:

          -  Chronic renal insufficiency (GFR less than 15 mL/min); Heart surgery without CPB;
             Aortic procedures; Heart transplant or congenital heart disease; Prior use of
             Intra-Aortic Balloon Pump; Decompensated heart failure; Participation in other
             research protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eduesley Santana-Santos, RN, Ph.D</last_name>
    <phone>+551126615434</phone>
    <email>eduesley@oi.com.br</email>
  </overall_contact>
  <reference>
    <citation>Liaño F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996 Sep;50(3):811-8.</citation>
    <PMID>8872955</PMID>
  </reference>
  <reference>
    <citation>Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S2-22. doi: 10.1016/j.athoracsur.2009.05.053.</citation>
    <PMID>19559822</PMID>
  </reference>
  <results_reference>
    <citation>Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998 Feb 1;128(3):194-203.</citation>
    <PMID>9454527</PMID>
  </results_reference>
  <results_reference>
    <citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009 May 12;119(18):2444-53. doi: 10.1161/CIRCULATIONAHA.108.800011. Epub 2009 Apr 27.</citation>
    <PMID>19398670</PMID>
  </results_reference>
  <results_reference>
    <citation>Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999 May;14(5):1158-62.</citation>
    <PMID>10344355</PMID>
  </results_reference>
  <results_reference>
    <citation>Bahar I, Akgul A, Ozatik MA, Vural KM, Demirbag AE, Boran M, Tasdemir O. Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion. 2005 Oct;20(6):317-22.</citation>
    <PMID>16363316</PMID>
  </results_reference>
  <results_reference>
    <citation>Boldt J, Brenner T, Lang J, Kumle B, Isgro F. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg. 2003 Dec;97(6):1582-9. Retraction in: Anesth Analg. 2011 May;112(5):1146.</citation>
    <PMID>14633524</PMID>
  </results_reference>
  <results_reference>
    <citation>Fleming I, Hecker M, Busse R. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res. 1994 Jun;74(6):1220-6.</citation>
    <PMID>7514511</PMID>
  </results_reference>
  <results_reference>
    <citation>Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA. 2005 Jul 20;294(3):342-50.</citation>
    <PMID>16030279</PMID>
  </results_reference>
  <results_reference>
    <citation>Fisher AR, Jones P, Barlow P, Kennington S, Saville S, Farrimond J, Yacoub M. The influence of mannitol on renal function during and after open-heart surgery. Perfusion. 1998 May;13(3):181-6.</citation>
    <PMID>9638715</PMID>
  </results_reference>
  <results_reference>
    <citation>Hynninen MS, Niemi TT, Pöyhiä R, Raininko EI, Salmenperä MT, Lepäntalo MJ, Railo MJ, Tallgren MK. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2006 Jun;102(6):1638-45.</citation>
    <PMID>16717300</PMID>
  </results_reference>
  <results_reference>
    <citation>Benedetto U, Sciarretta S, Roscitano A, Fiorani B, Refice S, Angeloni E, Sinatra R. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg. 2008 Oct;86(4):1160-5. doi: 10.1016/j.athoracsur.2008.06.018.</citation>
    <PMID>18805152</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006 Jan;1(1):19-32. Epub 2005 Oct 19. Review.</citation>
    <PMID>17699187</PMID>
  </results_reference>
  <results_reference>
    <citation>Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000 Mar 13;160(5):685-93.</citation>
    <PMID>10724055</PMID>
  </results_reference>
  <results_reference>
    <citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005 Jan;16(1):162-8. Epub 2004 Nov 24.</citation>
    <PMID>15563569</PMID>
  </results_reference>
  <results_reference>
    <citation>Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S43-62. doi: 10.1016/j.athoracsur.2009.05.055.</citation>
    <PMID>19559824</PMID>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Eduesley Santana Santos</investigator_full_name>
    <investigator_title>RN, Ph.D</investigator_title>
  </responsible_party>
  <keyword>early goal direct therapy</keyword>
  <keyword>preventive strategies</keyword>
  <keyword>cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

